<VariationArchive VariationID="1677198" VariationName="NM_000138.5(FBN1):c.51_52del (p.Leu17fs)" VariationType="Deletion" Accession="VCV001677198" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-05" DateCreated="2022-04-23" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1668830" VariationID="1677198">
      <GeneList>
        <Gene Symbol="FBN1" FullName="fibrillin 1" GeneID="2200" HGNC_ID="HGNC:3603" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48408313" stop="48645709" display_start="48408313" display_stop="48645709" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48700502" stop="48937984" display_start="48700502" display_stop="48937984" Strand="-" />
          </Location>
          <OMIM>134797</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
        <Gene Symbol="LOC130057019" FullName="ATAC-STARR-seq lymphoblastoid silent region 6417" GeneID="130057019" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48644684" stop="48644733" display_start="48644684" display_stop="48644733" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000138.5(FBN1):c.51_52del (p.Leu17fs)</Name>
      <CanonicalSPDI>NC_000015.10:48644717:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48644718" stop="48644719" display_start="48644718" display_stop="48644719" variantLength="2" positionVCF="48644717" referenceAlleleVCF="GCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48936915" stop="48936916" display_start="48936915" display_stop="48936916" variantLength="2" positionVCF="48936914" referenceAlleleVCF="GCT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>L17fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000138.5" sequenceAccession="NM_000138" sequenceVersion="5" change="c.51_52del" MANESelect="true">
            <Expression>NM_000138.5:c.51_52del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000129.3" sequenceAccession="NP_000129" sequenceVersion="3" change="p.Leu17fs">
            <Expression>NP_000129.3:p.Leu17fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.48644718_48644719del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.48644718_48644719del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.48936915_48936916del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.48936915_48936916del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008805.2" sequenceAccession="NG_008805" sequenceVersion="2" change="g.6070_6071del">
            <Expression>NG_008805.2:g.6070_6071del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_778" sequenceAccession="LRG_778">
            <Expression>LRG_778:g.6070_6071del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_778t1" sequenceAccession="LRG_778t1">
            <Expression>LRG_778t1:c.51_52del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2140787769" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000138.5(FBN1):c.51_52del (p.Leu17fs) AND Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections" Accession="RCV002223056" Version="1">
        <ClassifiedConditionList TraitSetID="22117">
          <ClassifiedCondition DB="MedGen" ID="CN229799">Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-28" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000138.5(FBN1):c.51_52del (p.Leu17fs) AND multiple conditions" Accession="RCV003774648" Version="1">
        <ClassifiedConditionList TraitSetID="10731">
          <ClassifiedCondition DB="MedGen" ID="C4707243">Familial thoracic aortic aneurysm and aortic dissection</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0024796">Marfan syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-13" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-04-23" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17657824</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19293843</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="10731" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2645" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Marfan syndrome</ElementValue>
                <XRef ID="MONDO:0007947" DB="MONDO" />
                <XRef ID="19346006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan's syndrome</ElementValue>
                <XRef ID="Marfan+syndrome/4466" DB="Genetic Alliance" />
                <XRef ID="19346006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFAN SYNDROME, TYPE I</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan syndrome, classic</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MFS1</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MFS</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6975" />
                <XRef ID="6975" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FBN1-related Marfan syndrome (Marfan syndrome), a systemic disorder of connective tissue with a high degree of clinical variability, comprises a broad phenotypic continuum ranging from mild (features of Marfan syndrome in one or a few systems) to severe and rapidly progressive neonatal multiorgan disease. Cardinal manifestations involve the ocular, skeletal, and cardiovascular systems. Ocular findings include myopia (&gt;50% of affected individuals); ectopia lentis (seen in approximately 60% of affected individuals); and an increased risk for retinal detachment, glaucoma, and early cataracts. Skeletal system manifestations include bone overgrowth and joint laxity; disproportionately long extremities for the size of the trunk (dolichostenomelia); overgrowth of the ribs that can push the sternum in (pectus excavatum) or out (pectus carinatum); and scoliosis that ranges from mild to severe and progressive. The major morbidity and early mortality in Marfan syndrome relate to the cardiovascular system and include dilatation of the aorta at the level of the sinuses of Valsalva (predisposing to aortic tear and rupture), mitral valve prolapse with or without regurgitation, tricuspid valve prolapse, and enlargement of the proximal pulmonary artery. Severe and prolonged regurgitation of the mitral and/or aortic valve can predispose to left ventricular dysfunction and occasionally heart failure. With proper management, the life expectancy of someone with Marfan syndrome approximates that of the general population.</Attribute>
                <XRef ID="NBK1335" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FBN1-Related Marfan Syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301510</ID>
                <ID Source="BookShelf">NBK1335</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987429</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2012">
                <ID Source="PubMed">22237449</ID>
              </Citation>
              <Citation Type="general" Abbrev="CSANZ, 2007">
                <ID Source="PubMed">17188935</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA, 2004">
                <ID Source="PubMed">15184297</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Marfan.pdf</URL>
                <CitationText>Orphanet, Marfan Syndrome, 2007</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Loeys et al., 2010">
                <ID Source="PubMed">20591885</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAP, 2013">
                <ID Source="PubMed">24081994</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="CSANZ, 2017">
                <ID Source="PubMed">28161018</ID>
              </Citation>
              <XRef ID="284963" DB="Orphanet" />
              <XRef ID="558" DB="Orphanet" />
              <XRef ID="C0024796" DB="MedGen" />
              <XRef ID="MONDO:0007947" DB="MONDO" />
              <XRef Type="MIM" ID="154700" DB="OMIM" />
            </Trait>
            <Trait ID="16634" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="MONDO:0019625" DB="MONDO" />
                <XRef ID="91387" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysms and dissections</ElementValue>
                <XRef ID="UWMG_7008129" DB="CSER _CC_NCGL, University of Washington" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="Thoracic+Aortic+Aneurysms+and+Aortic+Dissections/9386" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TAAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EDS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2249" />
                <XRef ID="2249" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301299</ID>
                <ID Source="BookShelf">NBK1120</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <XRef ID="91387" DB="Orphanet" />
              <XRef ID="C4707243" DB="MedGen" />
              <XRef ID="MONDO:0019625" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS607086" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="22117" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33202" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections</ElementValue>
              </Name>
              <XRef ID="CN229799" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4891299" SubmissionDate="2022-04-19" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000138.4:c.51_52delAG|MedGen:CN229799" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002500675" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: FBN1 c.51_52delAG (p.Leu17PhefsX37) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251270 control chromosomes. To our knowledge, no occurrence of c.51_52delAG in individuals affected with Marfan Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000138.4:c.51_52delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN229799" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11350627</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8547303" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="18355398|MedGen:C0024796;CN118826" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004593575" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17657824</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19293843</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu17Phefs*37) in the FBN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FBN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1677198). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.48936915_48936916del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024796" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN118826" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8547303" TraitType="Disease" MappingType="XRef" MappingValue="CN118826" MappingRef="MedGen">
        <MedGen CUI="C4707243" Name="Familial thoracic aortic aneurysm and aortic dissection" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4891299" TraitType="Disease" MappingType="XRef" MappingValue="CN229799" MappingRef="MedGen">
        <MedGen CUI="CN229799" Name="Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8547303" TraitType="Disease" MappingType="XRef" MappingValue="C0024796" MappingRef="MedGen">
        <MedGen CUI="C0024796" Name="Marfan syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

